Stockreport

CytoReason extends its collaboration with Sanofi to advance AI-driven drug discovery [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF TEL AVIV, Israel Jan. 9, 2026 /PRNewswire/ -- CytoReason, a leader in AI-powered computational disease modeling, today announced the expansion of its collaboration with [Read more]